Gong Jie, Gao Fengwei, Xie Qingyun, Zhao Xin, Lei Zehua
Department of Hepatobiliary and Pancreatic Spleen, Leshan People's Hospital, Leshan, China.
Front Surg. 2021 Aug 30;8:726217. doi: 10.3389/fsurg.2021.726217. eCollection 2021.
We performed a meta-analysis to evaluate the outcomes of minimally invasive surgery and open surgery in the simultaneous resection of colorectal cancer and synchronous colorectal liver metastases. A systematic literature search up to April 2021 was done and 13 studies included 1,181 subjects with colorectal cancer and synchronous colorectal liver metastases at the start of the study; 425 of them were using minimally invasive surgery and 756 were open surgery. They were reporting relationships between the outcomes of minimally invasive surgery and open surgery in the simultaneous resection of colorectal cancer and synchronous colorectal liver metastases. We calculated the odds ratio (OR) or the mean difference (MD) with 95% CIs to assess the outcomes of minimally invasive surgery and open surgery in the simultaneous resection of colorectal cancer and synchronous colorectal liver metastases using the dichotomous or continuous method with a random or fixed-effect model. Minimally invasive surgery in subjects with colorectal cancer and synchronous colorectal liver metastases was significantly related to longer operation time (MD, 35.61; 95% CI, 7.36-63.87, = 0.01), less blood loss (MD, -151.62; 95% CI, -228.84 to -74.40, < 0.001), less blood transfusion needs (OR, 0.61; 95% CI, 0.42-0.89, = 0.01), shorter length of hospital stay (MD, -3.26; 95% CI, -3.67 to -2.86, < 0.001), lower overall complications (OR, 0.59; 95% CI, 0.45-0.79, < 0.001), higher overall survival (OR, 1.66; 95% CI, 1.21-2.29, = 0.002), and higher disease-free survival (OR, 1.49; 95% CI, 1.13-1.97, = 0.005) compared to open surgery. Minimally invasive surgery in subjects with colorectal cancer and synchronous colorectal liver metastases may have less blood loss, less blood transfusion needs, shorter length of hospital stay, lower overall complications, higher overall survival, and higher disease-free survival with longer operation time compared with the open surgery. Furthers studies are required to validate these findings.
我们进行了一项荟萃分析,以评估在同时切除结直肠癌和同步性结直肠肝转移瘤时微创手术和开放手术的疗效。截至2021年4月进行了系统的文献检索,13项研究纳入了1181名在研究开始时患有结直肠癌和同步性结直肠肝转移瘤的受试者;其中425例采用微创手术,756例采用开放手术。这些研究报告了在同时切除结直肠癌和同步性结直肠肝转移瘤时微创手术和开放手术疗效之间的关系。我们使用二分法或连续法以及随机或固定效应模型计算了比值比(OR)或平均差(MD)及其95%置信区间(CI),以评估在同时切除结直肠癌和同步性结直肠肝转移瘤时微创手术和开放手术的疗效。与开放手术相比,结直肠癌和同步性结直肠肝转移瘤患者的微创手术与更长的手术时间(MD,35.61;95%CI,7.36 - 63.87,P = 0.01)、更少的失血量(MD,-151.62;95%CI,-228.84至-74.40,P < 0.001)、更少的输血需求(OR,0.61;95%CI,0.42 - 0.89,P = 0.01)、更短的住院时间(MD,-3.26;95%CI,-3.67至-2.86,P < 0.001)、更低的总体并发症发生率(OR,0.59;95%CI,0.45 - 0.79,P < 0.001)、更高的总生存率(OR,1.66;95%CI,1.21 -